TOYOTA、ヴィッツに特別仕様車を設定

ENGLISH
|
JAPANESE
|
CONNECT WITH US:

2017年10月02日 13時30分

Source: Toyota Motor Corporation

TOYOTA、ヴィッツに特別仕様車を設定

豊田, 2017年10月02日 - (JCN Newswire) - TOYOTAは、ヴィッツに特別仕様車F“Safety Edition”を設定し、全国のネッツ店を通じて、10月2日に発売した。

今回の特別仕様車は「HYBRID F」、「F」をベースに衝突回避支援パッケージ「Toyota Safety Sense C」を特別装備。また、内外装においては、アウトサイドドアハンドルやインサイドドアハンドルなどにメッキ加飾を施したほか、ブルーブラック＆ブラックの専用ファブリックシートを特別装備。さらに、お客様に好評いただいているスマートエントリー＆スタートシステムとイルミネーテッドエントリーシステム＊も装備し、安全性に配慮しながらお洒落感を加えた魅力ある仕様としている。外板色にはJewela専用色のダークブルーマイカ、ボルドーマイカメタリックを含む全6色を設定した。

＊スマートキーの検知・ドア開閉時のパワーまたはエンジンスイッチの自動点灯・消灯機能を追加

本リリースの詳細は下記URLをご参照ください。
http://newsroom.toyota.co.jp/jp/detail/mail/18842601

概要：トヨタ自動車株式会社

詳細は http://toyota.jp/ をご覧ください。

Source: Toyota Motor Corporation
セクター: 自動車

Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Latest Release

CleverTap

CleverTap Recognized as a 'Strong Performer' in the Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 22, 2024 22:42 JST

Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST

NaaS Technology Inc.

NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST

Honda Motor Co, Ltd

Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST

Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Nov 21, 2024 09:00 JST

Lexaria Bioscience

ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
Nov 20, 2024 23:05 JST

Mitsubishi Heavy Industries, Ltd.

Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Nov 20, 2024 15:30 JST

Eisai

Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 11:51 JST

Eisai

Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 10:24 JST

Kingsoft Corporation Limited

Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 18:54 JST

Olympus

NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Nov 19, 2024 15:30 JST

Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
Nov 19, 2024 09:02 JST

CleverTap

CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 18, 2024 23:30 JST

NEC Corporation

World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
Nov 18, 2024 17:29 JST

Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business
Nov 18, 2024 12:31 JST

Toyota Motor Corporation

Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round
Nov 18, 2024 09:25 JST

COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding
Nov 16, 2024 18:00 JST

Mitsubishi Heavy Industries, Ltd.

Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY EMERALD in Shimonoseki
Nov 15, 2024 18:58 JST

Eisai

Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)
Nov 15, 2024 17:33 JST

Eisai

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
Nov 15, 2024 14:31 JST

More Latest Release >>